Central sleep apnea in patients with chronic heart failure

Sorokina K.V.; Brovko M.Yu.; Poltavskaya M.G.

doi:https://doi.org/10.17116/jnevro201911904299

Close metadata

Recommended articles:

Mitochondrial cytoprotectors in complex therapy of chronic heart failure in patients with metabolic syndrome or type 2 diabetes mellitus: subanalysis of the INDIKOR study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):566-576

Clinical markers of inflammation and myocardial remodeling in patients with chronic obstructive pulmonary diseases and chronic heart failure. Russian Journal of Preventive Medicine. 2025;(11):72-78

Changes in NT-proBNP and sST2 concentrations after decompensated heart failure and long-term prognosis of patients with CHF and reduced LVEF. Russian Cardiology Bulletin. 2025;(4):38-46

Laboratory predictors of severe course and prognosis of chronic heart failure in patients after COVID-19 recovery. Laboratory Service. 2025;(4):20-26

Relationship between chronic heart and venous insufficiency: possible mechanisms and clinical research findings. Russian Journal of Preventive Medicine. 2026;(2):103-108

Treatment efficacy and adherence in patients with chronic heart failure according to the chronic heart failure registry in the Tyumen region. Russian Cardiology Bulletin. 2026;(1):60-67

Association of red blood cell distribution width with aggregation parameters in patients with chronic heart failure. Russian Cardiology Bulletin. 2026;(1):68-74

Prevention of severe nocturnal hypoxemia in COPD patients at high altitude. (Results of a randomized controlled trial). Journal of Respiratory Medicine. 2026;(1):7-14

Comorbidity in patients with obstructive sleep apnea. Part 2. The most clinically significant comorbid interactions. Russian Journal of Preventive Medicine. 2026;(4):96-102

Hemodynamic response to initial stage of anesthesia in coronary artery bypass grafting: a prospective clinical study. Russian Journal of Anesthesiology and Reanimatology. 2026;(2):32-38

Abstract:

Cheyne—Stokes respiration (CSR) is a form of sleep-disordered breathing seen in approximately half of patients with chronic heart failure and low left ventricular ejection fraction. The authors describe clinical features of CSR, mortality rate, treatment variants. Effects of continuous positive airway pressure (CPAP), bi-level ventilation, adaptive servoventilation (ASV) in patients with CSR and chronic heart failure are discussed. Diuretic acetazolamide is one more therapeutic option for CSR. It improves central sleep apnea and related daytime symptoms in patients with heart failure.

Keywords:

Cheyne—Stokes respiration

central sleep apnea

chronic heart failure

CPAP

BiPAP

ASV

acetazolamide

Authors:

Sorokina K.V.

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Brovko M.Yu.

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Poltavskaya M.G.

Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

Cheyne J. A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hosp Reports. 1818;2:216-222.
Stokes W. The diseases of the heart and aorta. Dublin: Hodges & Smith; 1854.
American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3-rd edition. Darien, IL: American Academy of Sleep Medicine; 2014.
Sleep-Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667-689.
Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106(1):21-28. https://doi.org/10.1016/j.ijcard.2004.12.068
Ferrier K, Campbell A, Yee B, Richards M, O’Meeghan T, Weatherall M, Neill A. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005;128(4):2116-2122. https://doi.org/10.1378/chest.128.4.2116
Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, Ruttanaumpawan P, Tomlinson G, Bradley TD. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49(15):1625-1631. https://doi.org/10.1016/j.jacc.2006.12.046
Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160(4):1101-1106. https://doi.org/10.1164/ajrccm.160.4.9903020
Zilberman M, Silverberg DS, Bits I, Steinbruch S, Wexler D, Sheps D, Schwartz D, Oksenberg A. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. Am Heart J. 2007;154(5):870-876. https://doi.org/10.1016/j.ahj.2007.07.034
Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med. 2002;165(9):1245-1250. https://doi.org/10.1164/rccm.200110-022OC
Yumino D, Bradley TD. Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc. 2008;5(2):226-236. https://doi.org/10.1513/pats.200708-129MG
Andreas S, Hagenah G, Moller C, Werner GS, Kreuzer H. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol. 1996;78(11):1260-1264.
Roebuck T, Solin P, Kaye DM, Bergin P, Bailey M, Naughton MT. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J. 2004;23(5):735-740. https://doi.org/10.1183/09031936.04.00060404
Naughton MT. Pro: persistent central sleep apnea/Hunter-Cheyne-Stokes breathing, despite best guideline-based therapy of heart failure with reduced ejection fraction, is a compensatory mechanism and should not be suppressed. J Clin Sleep Med. 2018;14(6):909-914. https://doi.org/10.5664/jcsm.7146
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99(11):1435-1440.
Corra U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113(1):44-50. https://doi.org/10.1161/CIRCULATIONAHA.105.543173
Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49(20):2028-2034. https://doi.org/10.1016/j.jacc.2007.01.084
Javaheri S, Brown LK, Khayat R. Con: persistent central sleep apnea/Hunter-Cheyne-Stokes breathing, despite best guideline-based therapy of heart failure with reduced ejection fraction, is not a compensatory mechanism and should be suppressed. J Clin Sleep Med. 2018;14(6):915-921. https://doi.org/10.5664/jcsm.7148
Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep. 2012;35(1):17-40. https://doi.org/10.5665/sleep.1580
Aurora RN, Bista SR, Casey KR, Chowdhuri S, Kristo DA, Mallea JM, Ramar K, Rowley JA, Zak RS, Heald JL. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: «The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses». J Clin Sleep Med. 2016;12(5):757-761. https://doi.org/10.5664/jcsm.5812
Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, Buyse B, De Backer W, Eckert DJ, Grote L, Hagmeyer L, Hedner J, Jennum P, La Rovere MT, Miltz C, McNicholas WT, Montserrat J, Naughton M, Pepin JL, Pevernagie D, Sanner B, Testelmans D, Tonia T, Vrijsen B, Wijkstra P, Levy P. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J. 2017;49(1):1600959. https://doi.org/10.1183/13993003.00959-2016
Sinha AM, Skobel EC, Breithardt OA, Norra C, Markus KU, Breuer C, Hanrath P, Stellbrink C. Cardiac resynchronization therapy improves central sleep apnea and Cheyne—Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol. 2004;44(1):68-71. https://doi.org/10.1016/j.jacc.2004.03.040
Vazir A, Hastings PC, Morrell MJ, Pepper J, Henein MY, Westaby S, Poole-Wilson PA, Cowie MR, Simonds AK. Resolution of central sleep apnoea following implantation of a left ventricular assist device. Int J Cardiol. 2010;138(3):317-319. https://doi.org/10.1016/j.ijcard.2008.06.072
Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9(3):251-257. https://doi.org/10.1016/j.ejheart.2006.08.003
Naughton MT, Benard DC, Rutherford R, Bradley TD. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1598-1604. https://doi.org/10.1164/ajrccm.150.6.7952621
Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med. 1995;151(1):92-97. https://doi.org/10.1164/ajrccm.151.1.7812579
Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353(19):2025-2033. https://doi.org/10.1056/NEJMoa051001
Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25):3173-3180. https://doi.org/10.1161/CIRCULATIONAHA.106.683482
Teschler H, Döhring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med. 2001;164(4):614-619. https://doi.org/10.1164/ajrccm.164.4.9908114
Philippe C, Stoïca-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Rouault S, d’Ortho MP. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart. 2006;92(3):337-342. https://doi.org/10.1136/hrt.2005.060038
Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med. 2015;373(12):1095-1105. https://doi.org/10.1056/NEJMoa1506459
Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne—Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol. 1996;27(6):1486-1490. https://doi.org/10.1016/0735-1097(96)00024-1
Lorenzi-Filho G, Rankin F, Bies I, Bradley TD. Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med. 1999;159(5 Pt 1):1490-1498. https://doi.org/10.1164/ajrccm.159.5.9810040
Sasayama S, Izumi T, Matsuzaki M, Matsumori A, Asanoi H, Momomura S, Seino Y, Ueshima K. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J. 2009;73(7):1255-1262. https://doi.org/10.1253/circj.CJ-08-1210
Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996;27(2):353-357. https://doi.org/10.1016/0735-1097(95)00474-2
Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle G. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996;335(8):562-567. https://doi.org/10.1056/NEJM199608223350805
Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Effect of ventilatory drive on CO2 sensitivity below eupnea during sleep. Am J Critical Care Med. 2002;165(9):1251-1259. https://doi.org/10.1164/rccm.2110041
Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173(2):234-237. https://doi.org/10.1164/rccm.200507-1035OC